AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Malignant Solid Neoplasm

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: MT027 CAR-T cells A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) NCT07785609Phase 24 sites๐Ÿ“ San Antonio๐Ÿ“ Hong Kong๐Ÿ“ Bellinzona Merck Sharp & Dohme LLC ยท Tests: MK-2010, Sacituzumab tirumotecan, Histamine H1 Receptor Antagonist, Histamine H2 Receptor Antagonist, Acetaminophen (orโ€ฆ A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Nashville RasCal Therapeutics, Inc. ยท Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion Increasing Knowledge and Interest in Cancer Clinical Trials NCT06501040NA1 site๐Ÿ“ Detroit Hayley Thompson ยท Tests: Web-based Educational Intervention, Questionnaire Administration Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers NCT06606990Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors NCT07387068Phase 112 sites๐Ÿ“ New Haven๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success Genmab ยท Tests: GEN1079 Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors NCT07644650Phase 11 site๐Ÿ“ Shanghai Mabsoft Therapeutics (Shanghai) Co., Ltd. ยท Tests: MST-168 Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites๐Ÿ“ Fairway๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Metarrestin JSKN022 in Subjects With Advanced Malignant Solid Tumors NCT07292402Phase 11 site๐Ÿ“ Guangzhou Jiangsu Alphamab Biopharmaceuticals Co., Ltd ยท Tests: JSKN022 CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Study of MHB088C for Patients With Advanced Solid Malignant Tumors NCT07102004Phase 1, Phase 21 site๐Ÿ“ Beijing Qilu Pharmaceutical Co., Ltd. ยท Tests: MHB088C for Injection Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma NCT05830058Phase 22 sites๐Ÿ“ Duarte๐Ÿ“ Irvine City of Hope Medical Center ยท Tests: Biospecimen Collection, Computed Tomography, Positron Emission Tomography, Questionnaire Administration, Stereotactic Bโ€ฆ Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial NCT06470971Phase 21 site๐Ÿ“ Columbus Yuanquan Yang ยท Tests: Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Biopsy, Biospecimen Collection, Bone Scan Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors NCT04879121Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Larotrectinib Sulfate Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors NCT05141474EARLY Phase 11 site๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD) Regimen, Interleukin-2 A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) NCT06979596Phase 260 sites๐Ÿ“ Anchorage๐Ÿ“ Miami Beach๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Opevesostat, Fludrocortisone/ Fludrocortisone acetate, Dexamethasone/Dexamethasone acetate, Rescue Medications, Fulvestโ€ฆ Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors NCT07583654Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: CP-IL22BP mRNA intratumorally injection Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors NCT05749627NA1 site๐Ÿ“ Nanchang The First Affiliated Hospital of Nanchang University ยท Tests: Neoantigen peptide vaccine, Neoantigen-based DC immune preparation Wisconsin Ginseng for Decreasing Cancer Related Fatigue NCT06395441Phase 315 sites๐Ÿ“ Albert Lea๐Ÿ“ Bemidji๐Ÿ“ Brainerd Mayo Clinic ยท Tests: American Ginseng, Placebo Administration, Questionnaire Administration Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors NCT06658951NA1 site๐Ÿ“ Zhengzhou UTC Therapeutics Inc. ยท Tests: Anti-HER2 CAR-T cells Atamparib in Patients With Advanced Solid Tumors NCT07374419Phase 1, Phase 21 site๐Ÿ“ Shanghai Nerviano Medical Sciences (Shanghai) Ltd. ยท Tests: atamparib escalation levels, atamparib RP2D A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors NCT07028281Phase 21 site๐Ÿ“ Jinan Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-4849ใ€SHR-1316ใ€SHR-8068ใ€BP102ใ€carboplatinใ€cisplatin A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 NCT06240728Phase 18 sites๐Ÿ“ Baltimore๐Ÿ“ Boston๐Ÿ“ The Bronx NextPoint Therapeutics, Inc. ยท Tests: NPX887 A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) NCT05865002Phase 137 sites๐Ÿ“ Vijayawada๐Ÿ“ Visakhapatnam๐Ÿ“ Chandigarh Aurigene Discovery Technologies Limited ยท Tests: AUR107 Study of LM-299 in Subjects Advanced Malignant Tumors NCT06650566Phase 1, Phase 26 sites๐Ÿ“ Perth๐Ÿ“ Xinxiang๐Ÿ“ Liaocheng LaNova Medicines Limited ยท Tests: LM-299 Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Biospecimen Collection, Immune Checkpoint Inhibitor Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial NCT04693468Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Axitinib, Crizotinib, Palbociclib Isethionate, Talazoparib Tosylate CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites๐Ÿ“ Denver๐Ÿ“ Chicago๐Ÿ“ Grand Rapids Context Therapeutics Inc. ยท Tests: CT-95 IBI343 in Combination Therapy for Advanced Malignant Solid Tumors NCT07483554Phase 21 site๐Ÿ“ Hangzhou Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI343,Gemcitabine, Albumin-bound Paclitaxel
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy